Moneycontrol PRO
HomeNewsNirma

Nirma

Jump to
  • Nirma Rs 1,343 crore open offer to buy more stake in Glenmark Life Sciences to start on Feb 15

    Nirma Rs 1,343 crore open offer to buy more stake in Glenmark Life Sciences to start on Feb 15

    The opening date (commencement of the tendering period) for the open offer has been fixed on February 15, 2024, and will close on February 29, 2024, as per the letter of offer, the letter said.

  • Nirma gets CCI nod for picking up majority stake in Glenmark Life Sciences

    Nirma gets CCI nod for picking up majority stake in Glenmark Life Sciences

    In September this year, Glenmark Pharmaceuticals said its board has approved to divest 75 per cent stake in its subsidiary GLS to Nirma Ltd for Rs 5,651.5 crore.

  • A golden goose gone: Why Glenmark Pharma’s investors are unhappy with Nirma deal

    A golden goose gone: Why Glenmark Pharma’s investors are unhappy with Nirma deal

    Glenmark Pharma has hived off a 75 percent stake in Glenmark Life Sciences, which accounted for nearly 11 percent of its consolidated top line, and had a 20 percent EBITDA contribution, to clear debt

  • Glenmark Life Sciences deal to reduce parent’s debt, make it net cash positive: CMD

    Glenmark Life Sciences deal to reduce parent’s debt, make it net cash positive: CMD

    Saldhana added that the management of Glenmark Lifesciences will remain intact

  • Nirma makes big pharma push; acquires 75% in Glenmark Life Sciences for Rs 5,651 cr

    Nirma makes big pharma push; acquires 75% in Glenmark Life Sciences for Rs 5,651 cr

    With this acquisition, Nirma group founded by Dr Karsanbhai Patel has forayed into the API segment. Glenmark Pharma, the parent of Glenmark Life Sciences will use the deal proceeds towards repayment of debt

  • ChrysCapital joins race to buy Glenmark Life Sciences for around Rs 7,000 cr

    ChrysCapital joins race to buy Glenmark Life Sciences for around Rs 7,000 cr

    The board of Glenmark Pharmaceuticals is said to take a decision regarding the sale soon and the amount received will be used to repay the debt of Rs 2,904 crore

  • Nirma to raise up to Rs 7,000 crore for acquisition, expansion of existing plants

    Nirma to raise up to Rs 7,000 crore for acquisition, expansion of existing plants

    Nirma has indicated that it will make large acquisitions in the domestic or overseas market to the tune of Rs 5,000-7,000 crore as part of its diversification plan.

  • Cement sale to add shine to Emami’s valuation

    Cement sale to add shine to Emami’s valuation

  • Webcomic: How Karsanbhai Patel created a low-cost detergent and made Nirma a household name

    Webcomic: How Karsanbhai Patel created a low-cost detergent and made Nirma a household name

    Latest in the Moneycontrol Graphic Spot: The Nirma story.

  • Import of a chemical from 3 nations to face antidumping duty

    Import of a chemical from 3 nations to face antidumping duty

    Tamil Nadu Petroproducts and Nirma Ltd had jointly filed the application for anti-dumping investigations into import of 'Linear Alkyl Benzene' from these countries.

  • Nirma raises Rs 4,000 cr debt to fund Lafarge deal

    Nirma raises Rs 4,000 cr debt to fund Lafarge deal

    "The Rs 4,000-crore five-year bond sale by Nirma offers a yield of 8.68 percent was oversubscribed 1.5 times. This is the largest rupee bond sale for a leveraged acquisition as also the largest AA-rated debt instrument," investment banking sources told PTI here.

  • Lafarge has got itself a sweet deal with Nirma: Anil Singhvi

    Lafarge has got itself a sweet deal with Nirma: Anil Singhvi

    Although the valuations of the deal look demanding, Anil Singhvi, Chairman of Ican Investment Advisors believes this is because it is sale of a fine-tuned business and not cement assets.

  • Nirma to raise Rs 4k cr to fund Lafarge buy; ropes in bankers

    Nirma to raise Rs 4k cr to fund Lafarge buy; ropes in bankers

    Earlier in the day, Swiss cement giant LafargeHolcim announced it has entered into an agreement to sell its assets in Lafarge India to Nirma for USD 1.4 billion, or about Rs 9,400 crore.

  • Nirma to buy Lafarge's India cement assets for Rs 9,300 crore

    Nirma to buy Lafarge's India cement assets for Rs 9,300 crore

    Nirma on Monday confirmed that it has bought LarfargeHolicm's India assets for an enterprise value of USD 1.4 billion (Rs 9300 crore plus) for 11 million tonne capacity.

  • Nirma joins race to acquire Lafarge's India assets: Sources

    Nirma joins race to acquire Lafarge's India assets: Sources

    French cement maker Lafarge has been looking to sell its 11 million tonne cement assets in India. It had shortlisted companies like Piramal GRoup, JSW Group and Cemex, learns CNBC-TV.

  • Dishman Pharma up 3%, may sell land in Gujarat to cut debt

    Dishman Pharma up 3%, may sell land in Gujarat to cut debt

    The drug company is in talks to sell its 175 hectares of land in Gujarat to Nirma for about Rs 650 crore, as it is reeling under a burden of Rs 800 crore debt, including current maturity of long term loans.

  • Nirma Washed Out!

    Nirma Washed Out!

    Nirma‘s 7-year battle is finally over. The company made an open offer but after discovering it was unviable asked to permission to withdraw it. SEBI said no, SAT said no and this month the Supreme Court said no as well on grounds that such a practice will destabilize the securities market.

  • Spot the opportunity

    Spot the opportunity

    Ravi Kiran reveals how you can identify a good business opportunity

  • Surat draws SME Mentor Growth Series to a high

    Surat draws SME Mentor Growth Series to a high

    The SME Mentor series concluded the 10-city journey at Surat in an event that saw the who‘s who of Surat SMEs, hosted at the Taj Gateway. The series commenced at Kolkata and travelled to New Delhi, Bangalore, Mumbai, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh and Surat.

  • Nirma Jun '11 sales at Rs 884.73 crore

    Nirma Jun '11 sales at Rs 884.73 crore

    Nirma has reported a sales turnover of Rs 884.73 crore and a net profit of Rs 51.32 crore for the quarter ended Jun '11

  • No play left in Cairn India open offer: Edelweiss Capital

    No play left in Cairn India open offer: Edelweiss Capital

    Yogesh Radke, Senior Manager (Institutional Equities - Quantitative Research Desk) at Edelweiss Capital, in an interview with CNBC-TV18’s Udayan and Mitali Mukherjee, gave his strategy on investing in various scenarios.

  • SC orders environment study of Nirma's Guj cement plant

    SC orders environment study of Nirma's Guj cement plant

    Nirma touched an intraday high of Rs 258.00 and an intraday low of Rs 255.05. At 13:20 hrs the share was quoting at Rs 255.10, down Rs 0.15, or 0.06%. Supreme Court (SC) orders environment study of company's Gujarat cement plant. SC seeks to know if company's Gujarat cement plant is on wetland, reports CNBC-TV18.

  • Nirma terms MOEF directions as 'illegal'

    Nirma terms MOEF directions as 'illegal'

    In response to a direction by the Ministry of Environment and Forest (MOEF) to halt work on its cement plant at Bhavnagar district in Gujarat, Nirma Ltd has said that the orders had no binding on the company and termed it as completely "illegal".

  • 5 stocks on the verge of their 52-week high

    5 stocks on the verge of their 52-week high

    The markets closed on strong note, recovered almost what it lost in previous two sessions. The BSE Sensex gained 265 points or 1.46%, to close at 18,439.48 and Nifty was up 86 points or 1.58% at 5,531.50.

  • Nirma directed to stop work on new cement plant

    Nirma directed to stop work on new cement plant

    Environment Ministry directed immediate halt to work on three projects on a wetland in Gujarat being carried out by Nirma Ltd for allegedly violating green norms.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347